Our purpose to save lives drew us to our first indication: Therapeutic Drug Monitoring of Vancomycin

Vancomycin is a difficult to dose antibiotic commonly used in the critical care setting. It has a narrow therapeutic window, high toxicity, and clinicians get very little information to dose it accurately
Vancomycin is the most administered IV antibiotic in US hospitals 2
2Goodman, et. al, 2021
Up to 43% of adults develop vancomycin induced Acute Kidney Injury (AKI) 3
‍3Jeffres, et. al, 2007
Mortality rate of up to 33% of adults with vancomycin-induced AKI4
 4Cano, 2012
Nutromics’ patch will revolutionize clinicians' ability to keep patients in the therapeutic range, improving efficacy and minimizing toxic overdoses

Our solutions

arrow down
Vancomycin is an antibiotic used as a first-line treatment for life-threatening infections such as sepsis and methicillin-resistant staphylococcus aureus (MRSA)
Our long-term vision is one patch for every patient 
In the future, Nutromics will tackle some of the deadliest disease states in the hospital setting. 
Therapeutic Drug Monitoring
1
Vancomycin
Trade Secret
Acute kidney injury
3
Trade Secret
2
Trade Secret
Trade Secret
Sepsis
Troponin
Trade Secret
Trade Secret
Cardiovascular Disease
Infectious Disease
Treat infectious diseases and their life-threatening conditions such as sepsis
Cardiology
Someone in the US dies every 33 seconds from cardiovascular disease¹. Nutromics will enable real-time access to relevant cardiovascular biomarkers
Renal
Nutromics’ will unlock continuous monitoring for renal function and kidney injury biomarkers. Giving patients and clinicians additional safety controls of renally-cleared drugs
Source:
¹CDC (2024)

Travel through the body to see how the world’s first lab-on-a-patch® actually works

Watch how it works

Disclaimer: This product is currently in development and has not yet been approved by the FDA, or any regulatory body. The information presented in this video is for informational purposes only